Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone408-345-8886
Debt
Current Ratio3.29
Quick Ratio2.74
Price-To-Earnings
Sales & Book Value
Annual Sales$4.91 billion
Price / Sales4.58
Price / Cash Flow19.91
Price / Book4.92
Profitability
Net Income$316 million
Net Margins6.43%
Return on Assets10.56%
Miscellaneous
Employees14,800
OptionableOptionable
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies declared a quarterly dividend on Wednesday, November 14th. Shareholders of record on Monday, December 31st will be given a dividend of $0.164 per share on Wednesday, January 23rd. This represents a $0.66 annualized dividend and a yield of 0.93%. The ex-dividend date is Friday, December 28th. This is a boost from Agilent Technologies's previous quarterly dividend of $0.15. View Agilent Technologies' Dividend History.
How will Agilent Technologies' stock buyback program work?
Agilent Technologies announced that its board has authorized a stock repurchase plan on Monday, November 19th 2018, which authorizes the company to repurchase $1,750,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 8.8% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) issued its earnings results on Monday, November, 19th. The medical research company reported $0.81 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.74 by $0.07. The medical research company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.26 billion. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. The business's revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.67 earnings per share. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies updated its FY19 earnings guidance on Monday, November, 19th. The company provided EPS guidance of $3.00-3.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.97. The company issued revenue guidance of $5.13-5.17 billion, compared to the consensus revenue estimate of $5.19 billion.Agilent Technologies also updated its FY 2019 guidance to $3.00-3.05 EPS.
What price target have analysts set for A?
9 equities research analysts have issued 12-month price objectives for Agilent Technologies' shares. Their predictions range from $76.00 to $89.00. On average, they anticipate Agilent Technologies' stock price to reach $80.6667 in the next twelve months. This suggests a possible upside of 14.3% from the stock's current price. View Analyst Price Targets for Agilent Technologies.
What is the consensus analysts' recommendation for Agilent Technologies?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.
Has Agilent Technologies been receiving favorable news coverage?
Headlines about A stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Agilent Technologies earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news headlines about the medical research company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the next few days.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 58)
- Mr. Mark Doak, Sr. VP (Age 64)
- Mr. Jacob Thaysen, Sr. VP (Age 44)
- Mr. Robert W. McMahon, Sr. VP & CFO (Age 50)
- Mr. Rodney Gonsalves, Chief Accounting Officer, VP & Corp. Controller (Age 53)
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Factory Mutual Insurance Co. (0.25%), CHURCHILL MANAGEMENT Corp (0.02%), Gulf International Bank UK Ltd (0.02%), Cardinal Capital Management (0.02%), State of Alaska Department of Revenue (0.02%) and DNB Asset Management AS (0.02%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which institutional investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, State of Alaska Department of Revenue, Louisiana State Employees Retirement System and Fox Run Management L.L.C.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which institutional investors are buying Agilent Technologies stock?
A stock was purchased by a variety of institutional investors in the last quarter, including Factory Mutual Insurance Co., CHURCHILL MANAGEMENT Corp, DNB Asset Management AS, First Hawaiian Bank, Sit Investment Associates Inc., Gateway Investment Advisers LLC, Ipswich Investment Management Co. Inc. and Cardinal Capital Management. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $70.60.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $22.22 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 14,800 workers across the globe.
What is Agilent Technologies' official website?
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (NYSE A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
